about
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate CombinationVascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatmentHome telemonitoring study for Japanese patients with heart failure (HOMES-HF): protocol for a multicentre randomised controlled trialA single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of thoracic myelopathy: a multicenter prospective controlled trial.Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prCognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled Trial.A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancerSuccessful bridging strategy based on ICH E5 guideline for drugs approved in JapanInduction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapyAccumulation of activated invariant natural killer T cells in the tumor microenvironment after α-galactosylceramide-pulsed antigen presenting cellsIncreased platelet inhibition after switching from maintenance clopidogrel to prasugrel in Japanese patients with stable coronary artery disease
P50
Q27883669-014F2BB3-010E-465F-B603-EFEFD788EAE6Q35192184-34CB38D3-DC50-43B5-A497-EDF9A2428AA5Q36302754-01E5C3C4-668F-4388-8B12-A0108E448B83Q36649764-08F1B466-0B0D-497E-AAD0-35E96B3C9791Q36893647-8CACBF6A-F3B9-4D15-86D4-C168C6224354Q39008917-326F27E0-6521-4905-8195-F9EDC907077CQ40093870-07626648-C5FD-4CF7-A2D1-B7590B86B0F3Q42631310-ADD8D1FC-FEB1-42AC-A0A8-AB7533BB72BFQ42651328-75E44B44-B47D-4DFB-A069-F9B1368BCC56Q46601340-340EFC76-D32E-421D-84E1-9A29814078C0Q48054260-6C8EC617-895B-46B6-B43D-C9769562115CQ51833179-22054F9F-288C-4A64-9BF0-F7326CD191A1Q53273805-3B847A27-6F07-463F-A39D-2215A6B153ADQ79209407-D44C1ECD-7C1A-4092-87FD-069750D76A26Q81016527-5149E2F5-90E3-4843-B074-F06D8442BEBAQ83032142-B60D1C28-0A39-46B8-B183-1F35FCCC3864Q83995222-0A1C672D-457A-41A6-82BB-2773FE9FC8C9Q86008633-E8ED84F3-9915-4F77-9241-59D26B5B0302
P50
description
researcher ORCID ID=0000-0003-0186-9296
@en
wetenschapper
@nl
name
Hideki Hanaoka
@en
Hideki Hanaoka
@nl
type
label
Hideki Hanaoka
@en
Hideki Hanaoka
@nl
prefLabel
Hideki Hanaoka
@en
Hideki Hanaoka
@nl
P106
P31
P496
0000-0003-0186-9296